🇹🇷 Türkçe

Debate: Is Addiction a Brain Disease?

The Question

Should addiction be conceptualised as a chronic brain disease — analogous to diabetes, asthma, or hypertension — or is this framing scientifically overstated, reductive of agency, or misleading for treatment and policy?

Position A: Addiction Is a Chronic Brain Disease

Argument:

  • Addiction produces measurable, replicable neurobiological changes: D2 receptor downregulation, PFC hypometabolism, CRF system dysregulation, altered dopamine signalling — all persisting long after drug cessation.
  • The addiction cycle (binge/intoxication → withdrawal/negative affect → preoccupation/anticipation) maps onto specific circuits and neurochemical changes that worsen progressively, consistent with a disease process.
  • Heritability of 40–60% implicates biological vulnerability factors.
  • Brain imaging shows compulsive drug seeking persists even when individuals express desire to stop — consistent with loss of voluntary control mediated by circuit-level pathology.
  • Like other chronic relapsing diseases (diabetes, hypertension, asthma), addiction shows: individual differences in response to the same exposure, limited treatment efficacy, relapse after periods of remission.
  • Genetic variants in specific receptors (D1, μ-opioid, nicotinic α4/α5) causally affect vulnerability.

Key evidence: Koob & Volkow 2016 explicitly frame addiction within the chronic disease model.

Position B: The Brain Disease Model Is Overstated or Problematic

Argument:

  • Most people who use drugs — including addictive ones — do not become addicted. Exposure alone is not sufficient; the brain disease model may obscure the role of social, psychological, and environmental factors.
  • Many individuals recover from addiction without formal treatment, often through changes in environment, life circumstances, or motivation — inconsistent with an irreversible brain disease.
  • D2 deficits and PFC changes, while real, may partially reverse with sustained abstinence; the degree to which they are cause vs. consequence is contested.
  • Framing addiction as a disease can reduce perceived agency and self-efficacy, potentially undermining motivation-based and cognitive-behavioural treatments.
  • The chronic disease comparison is imperfect: diabetes and hypertension are not primarily defined by behavioural choices; addiction involves an interaction of neurobiology with voluntary behaviour that is difficult to cleanly separate.
  • Policy implications: disease framing can reduce stigma but may also shift responsibility entirely away from the individual, complicating harm-reduction and social approaches.

Current State of the Field

  • The brain disease model of addiction (BDMA) is the dominant framework in neuroscience and psychiatry (endorsed by NIDA, NIAAA, and major professional bodies).
  • Critics (e.g., Heyman, Lewis, Hart) argue the model is scientifically valid in its core claims but overstated or misapplied in public policy.
  • A nuanced view: addiction involves neurobiological vulnerability AND environmental context AND volitional behaviour — none of these fully explains it alone.
  • The field is moving toward integrating circuit-level biology with psychological, social, and developmental factors (biopsychosocial model).